Janet Stewart is a life sciences writer and editor, who completed both PhD course work and oral examinations in the Department of Microbiology and Immunology at McGill University, and holds an M.Sc. in Virology and Immunology.
Goal-oriented cognitive rehabilitation was better than standard treatment or relaxation therapy at helping dementia patients achieve goals, a study reported. It also led to patients getting more satisfaction from attaining ... Read more
After exposure to the herbicide paraquat, genes that may lead to Parkinson’s disease were identified using an innovative gene-editing technique. The study, “A CRISPR screen identifies a pathway required for ... Read more
GeneFo, an internet resource on genetic diseases, is offering a free online lecture featuring humorist and author Yvonne deSousa, who has a neurodegenerative illness. The topic of the Sept. 27 ... Read more
The U.S. Food and Drug Administration (FDA) has given a green light to Titan Pharmaceuticals to begin a first-in-human clinical trial testing an implant that provides continuous release of ropinirole ... Read more
The antipsychotics Clozaril (clozapine, or CLZ) and Nuplazid (pimavanserin, or PIM) are potential treatments for Parkinson’s disease psychosis (PDP) in patients with idiopathic Parkinson’s disease (iPD), whose cause is unknown. However, their use is ... Read more
Italian researchers found that when used along with standard medication, Normast (ultra-micronized palmitoylethanolamide, or um-PEA) helped lower both motor and non-motor symptoms in patients with advanced Parkinson’s disease (PD), and slowed ... Read more
Brazilian researchers discovered by accident that the antibiotic doxycycline prevented nerve cell damage in mice with Parkinson’s disease, a finding that was so exciting that they and colleagues from other ... Read more